13hon MSN
Legal questions swirl around FDA’s new expedited drug program, including who should sign off
A plan to slash Food and Drug Administration drug review times is raising alarms at the public health agency that's been ...
15hon MSN
Takeaways from the AP’s report on turmoil surrounding the FDA’s new fast-track drug program
Questions remain among top Food and Drug Administration officials over who has the appropriate legal authority to sign off on ...
1don MSN
Exclusive - US FDA delays two drug reviews in new voucher program after safety, efficacy concerns
The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the Trump administration's new fast-track ...
The U.S. Food and Drug Administration and the European Medicines Agency jointly issued principles for safe and responsible ...
Martin Makary, commissioner of the Food and Drug Administration, on the push against ultra processed foods and added sugar, ...
Here's full footage from a STAT event with former top FDA official Richard Pazdur, who expressed grave concern about ...
Friendly” labels on the packaging are becoming more common in U.S. supermarkets as a growing number of Americans try obesity ...
The US Food and Drug Administration found no increased risk of suicidal behavior or ideation linked to popular weight-loss ...
A new study co-written by a University of Illinois Urbana-Champaign expert in operations management finds that drugs approved ...
The U.S. Food and Drug Administration (FDA) has granted full approval of Laverdia, a drug to treat dogs with lymphoma, a type ...
GlobalData on MSN
FDA prevails over EMA in 2025 novel drug approvals
This is eight fewer than the FDA, which approved 46 novel drugs in 2025 – sneaking in two regulatory decisions during the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results